Literature DB >> 2271852

Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.

A Frydén1, A Bengtsson, U Foberg, B Svenungsson, B Castor, A Kärnell, R Schvarcz, B Lindblom, E Kihlström.   

Abstract

OBJECTIVE: To find out whether a 10-14 days' course of antibiotics early in the course of reactive arthritis associated with enteric infections could reduce the severity and duration of the disease and whether the antibody response in patients with reactive arthritis associated with yersinia infection differed between those treated and those not treated with the antibiotics.
DESIGN: Prospective multicentre trial in which patients were randomised to treatment or no treatment with antibiotics. Patients were seen at three and six weeks and three, six, nine, 12, and 18 months after their first visit.
SETTING: Departments of infectious diseases in three hospitals in Linköping, Malmö, and Stockholm, Sweden. PATIENTS: 40 Consecutive patients who had had symptoms of reactive arthritis associated with enteric infection for less than four weeks.
INTERVENTIONS: 20 Patients were allocated to treatment with antibiotics and 20 patients did not receive antibiotics. All patients received non-steroidal anti-inflammatory drugs, and four also received intra-articular steroid injections after at least six weeks' observation. MAIN OUTCOME MEASURES: Arthritic symptoms assessed clinically and by using Ritchies' index; blood measurements reflecting inflammatory activity; serum IgG, IgM, and IgA antibody titres; HLA tissue type.
RESULTS: No difference was observed concerning duration of arthritis, grade of inflammation, and number of joints affected between patients treated and those not treated with antibiotics. Furthermore, there was no significant difference between the two groups in erythrocyte sedimentation rate and haptoglobin, IgG, and IgA concentrations. All values had returned to normal within three months. No patient developed chronic arthritis, but sustained slight arthralgia occurred in three patients. The HLA-B27 antigen was found in 23 (58%) of the patients, and its presence did not affect clinical outcome. The IgG, IgM, and IgA antibody responses were similar in patients treated with antibiotics and those not treated.
CONCLUSION: Short term antibiotic treatment has no beneficial effect on the clinical outcome of reactive arthritis associated with enteric infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271852      PMCID: PMC1664431          DOI: 10.1136/bmj.301.6764.1299

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies.

Authors:  J de Koning; J Heesemann; J A Hoogkamp-Korstanje; J J Festen; P M Houtman; P L van Oijen
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

Review 2.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

3.  Acute diarrhoea in adults: aetiology, clinical appearance and therapeutic aspects.

Authors:  B Svanteson; A Thorén; B Castor; G Barkenius; U Bergdahl; B Tufvesson; H B Hansson; R Möllby; I Juhlin
Journal:  Scand J Infect Dis       Date:  1988

Review 4.  Reiter's syndrome and reactive arthritis in perspective.

Authors:  A Keat
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

5.  Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni.

Authors:  A Svedhem; H Gunnarsson; B Kaijser
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

6.  Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis.

Authors:  A A Lindberg; T Holme
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

7.  Antibody responses in arthritic and uncomplicated Yersinia enterocolitica infections.

Authors:  P S Mattila; V Valtonen; M R Tuori; O Mäkelä
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

8.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

9.  Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.

Authors:  A Toivanen; R Lahesmaa-Rantala; R Vuento; K Granfors
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

10.  Yersinia enterocolitica arthritis in southern Sweden: a four-year follow-up study.

Authors:  L Marsal; S Winblad; F A Wollheim
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-11
View more
  16 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  A practical guide to the diagnosis and management of bone and joint infections.

Authors:  J T Mader; D Mohan; J Calhoun
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

4.  Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Parviainen; J Uksila; R Vainionpää; A Toivanen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 5.  Bone and joint infections in the elderly: practical treatment guidelines.

Authors:  J T Mader; M E Shirtliff; S Bergquist; J H Calhoun
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 6.  When is arthritis reactive?

Authors:  S S Hamdulay; S J Glynne; A Keat
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

7.  Reactive arthritis.

Authors:  B Svenungsson
Journal:  BMJ       Date:  1994-03-12

Review 8.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

9.  Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli.

Authors:  H Locht; K A Krogfelt
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

10.  Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Uksila; A Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.